Index by author
October 01, 1995; Volume 23,Issue 10
B
Benet, L Z
- You have accessStereoselective disposition of naproxen glucuronide in the rat.M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z BenetDrug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
Bergeron, R J
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Bhargava, R
- You have accessLiver volume as a determinant of drug clearance in children and adolescents.D J Murry, W R Crom, W E Reddick, R Bhargava and W E EvansDrug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
Bischer, A
- You have accessStereoselective disposition of naproxen glucuronide in the rat.M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z BenetDrug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
Bugelski, P J
- You have accessRenal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J BugelskiDrug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
C
Carbonaro, M A
- You have accessRenal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J BugelskiDrug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
Cashman, J R
- You have accessIn vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.A D Rodrigues, M J Kukulka, J L Ferrero and J R CashmanDrug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
Castle, P J
- You have accessHuman liver lauric acid hydroxylase activities.P J Castle, J L Merdink, J R Okita, S A Wrighton and R T OkitaDrug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
Chiu, S H
- You have accessIdentification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H ChiuDrug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
Coassolo, P
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Crom, W R
- You have accessLiver volume as a determinant of drug clearance in children and adolescents.D J Murry, W R Crom, W E Reddick, R Bhargava and W E EvansDrug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
Crooks, P A
- You have accessDetermination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.P A Crooks, M Li and L P DwoskinDrug Metabolism and Disposition October 1995, 23 (10) 1175-1177;
D
Davies, M I
- You have accessMicrodialysis sampling for hepatic metabolism studies. Impact of microdialysis probe design and implantation technique on liver tissue.M I Davies and C E LunteDrug Metabolism and Disposition October 1995, 23 (10) 1072-1079;
Davis, C B
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
- You have accessRenal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J BugelskiDrug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
Dean, D C
- You have accessIdentification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H ChiuDrug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
Demuth, S G
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
De Sousa, G
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Dimova, H
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Dwoskin, L P
- You have accessDetermination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.P A Crooks, M Li and L P DwoskinDrug Metabolism and Disposition October 1995, 23 (10) 1175-1177;
E
Endo, T
- You have accessInterindividual variation in carboxylesterase levels in human liver microsomes.M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T SatohDrug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
Evans, W E
- You have accessLiver volume as a determinant of drug clearance in children and adolescents.D J Murry, W R Crom, W E Reddick, R Bhargava and W E EvansDrug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
F
Faiman, M D
- You have accessIdentification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.A Madan, A Parkinson and M D FaimanDrug Metabolism and Disposition October 1995, 23 (10) 1153-1162;
Ferrero, J L
- You have accessIn vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.A D Rodrigues, M J Kukulka, J L Ferrero and J R CashmanDrug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
- You have accessIdentification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D RodriguesDrug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
Fredenburg, A M
- You have accessInfluence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.R A Yokel, A M Fredenburg, K A Meurer and T L SkinnerDrug Metabolism and Disposition October 1995, 23 (10) 1178-1180;
Fujisawa, M
- You have accessInterindividual variation in carboxylesterase levels in human liver microsomes.M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T SatohDrug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
G
Gupta, N
- You have accessVerlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A YergeyDrug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
H
Hara, S
- You have accessInterindividual variation in carboxylesterase levels in human liver microsomes.M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T SatohDrug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
Hart, T K
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
Hepburn, T W
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
- You have accessRenal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J BugelskiDrug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
Herzyk, D J
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
Hosokawa, M
- You have accessInterindividual variation in carboxylesterase levels in human liver microsomes.M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T SatohDrug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
Huskey, S W
- You have accessIdentification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H ChiuDrug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
I
Iwaki, M
- You have accessStereoselective disposition of naproxen glucuronide in the rat.M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z BenetDrug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
Iwata, N
- You have accessInterindividual variation in carboxylesterase levels in human liver microsomes.M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T SatohDrug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
J
Jaeck, D
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Juchau, M R
- You have accessXenopus laevis: a model system for the study of embryonic retinoid metabolism. III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis-retinoic acid and their dysmorphogenic effects in embryos during neurulation.J C Kraft and M R JuchauDrug Metabolism and Disposition October 1995, 23 (10) 1058-1071;
K
Kleiner, H E
- You have accessMetabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.S S Lau, H E Kleiner and T J MonksDrug Metabolism and Disposition October 1995, 23 (10) 1136-1142;
Kraft, J C
- You have accessXenopus laevis: a model system for the study of embryonic retinoid metabolism. III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis-retinoic acid and their dysmorphogenic effects in embryos during neurulation.J C Kraft and M R JuchauDrug Metabolism and Disposition October 1995, 23 (10) 1058-1071;
Kukulka, M J
- You have accessIn vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.A D Rodrigues, M J Kukulka, J L Ferrero and J R CashmanDrug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
Kwok, D C
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
L
Lau, S S
- You have accessMetabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.S S Lau, H E Kleiner and T J MonksDrug Metabolism and Disposition October 1995, 23 (10) 1136-1142;
Leland, M
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
Li, M
- You have accessDetermination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.P A Crooks, M Li and L P DwoskinDrug Metabolism and Disposition October 1995, 23 (10) 1175-1177;
Lin, J H
- You have accessSpecies similarities and differences in pharmacokinetics.J H LinDrug Metabolism and Disposition October 1995, 23 (10) 1008-1021;
Luchetta, G
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Lunte, C E
- You have accessMicrodialysis sampling for hepatic metabolism studies. Impact of microdialysis probe design and implantation technique on liver tissue.M I Davies and C E LunteDrug Metabolism and Disposition October 1995, 23 (10) 1072-1079;
M
Machinist, J M
- You have accessIdentification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D RodriguesDrug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
Madan, A
- You have accessIdentification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.A Madan, A Parkinson and M D FaimanDrug Metabolism and Disposition October 1995, 23 (10) 1153-1162;
Mayer, M D
- You have accessIdentification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D RodriguesDrug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
McDonagh, A F
- You have accessStereoselective disposition of naproxen glucuronide in the rat.M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z BenetDrug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
Merdink, J L
- You have accessHuman liver lauric acid hydroxylase activities.P J Castle, J L Merdink, J R Okita, S A Wrighton and R T OkitaDrug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
Meurer, K A
- You have accessInfluence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.R A Yokel, A M Fredenburg, K A Meurer and T L SkinnerDrug Metabolism and Disposition October 1995, 23 (10) 1178-1180;
Miller, R R
- You have accessIdentification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H ChiuDrug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
Monks, T J
- You have accessMetabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.S S Lau, H E Kleiner and T J MonksDrug Metabolism and Disposition October 1995, 23 (10) 1136-1142;
Murry, D J
- You have accessLiver volume as a determinant of drug clearance in children and adolescents.D J Murry, W R Crom, W E Reddick, R Bhargava and W E EvansDrug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
N
Nguyen, A C
- You have accessStereoselective disposition of naproxen glucuronide in the rat.M Iwaki, A Bischer, A C Nguyen, A F McDonagh and L Z BenetDrug Metabolism and Disposition October 1995, 23 (10) 1099-1103;
Nicoll-Griffith, D A
- You have accessVerlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A YergeyDrug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
O
Okita, J R
- You have accessHuman liver lauric acid hydroxylase activities.P J Castle, J L Merdink, J R Okita, S A Wrighton and R T OkitaDrug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
Okita, R T
- You have accessHuman liver lauric acid hydroxylase activities.P J Castle, J L Merdink, J R Okita, S A Wrighton and R T OkitaDrug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
P
Parkinson, A
- You have accessIdentification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.A Madan, A Parkinson and M D FaimanDrug Metabolism and Disposition October 1995, 23 (10) 1153-1162;
Perrin, J
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Porter, C
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
R
Rahmani, R
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Rasmusson, G H
- You have accessIdentification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.S W Huskey, D C Dean, R R Miller, G H Rasmusson and S H ChiuDrug Metabolism and Disposition October 1995, 23 (10) 1126-1135;
Reddick, W E
- You have accessLiver volume as a determinant of drug clearance in children and adolescents.D J Murry, W R Crom, W E Reddick, R Bhargava and W E EvansDrug Metabolism and Disposition October 1995, 23 (10) 1110-1116;
Rhodes, G R
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
Rodrigues, A D
- You have accessIn vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.A D Rodrigues, M J Kukulka, J L Ferrero and J R CashmanDrug Metabolism and Disposition October 1995, 23 (10) 1143-1152;
- You have accessIdentification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D RodriguesDrug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
S
Sanders, R A
- You have accessMinimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.S G Sastry, R A Sanders, J C Veltman and J B WatkinsDrug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
Sastry, S G
- You have accessMinimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.S G Sastry, R A Sanders, J C Veltman and J B WatkinsDrug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
Sato, Y
- You have accessInterindividual variation in carboxylesterase levels in human liver microsomes.M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T SatohDrug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
Satoh, T
- You have accessInterindividual variation in carboxylesterase levels in human liver microsomes.M Hosokawa, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato and T SatohDrug Metabolism and Disposition October 1995, 23 (10) 1022-1027;
Schaefer, W H
- You have accessRenal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J BugelskiDrug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
Schiller, C D
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Schreier, K M
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Shet, M S
- You have accessIdentification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.J M Machinist, M D Mayer, M S Shet, J L Ferrero and A D RodriguesDrug Metabolism and Disposition October 1995, 23 (10) 1163-1174;
Skinner, T L
- You have accessInfluence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.R A Yokel, A M Fredenburg, K A Meurer and T L SkinnerDrug Metabolism and Disposition October 1995, 23 (10) 1178-1180;
Sladek, N E
- You have accessHuman breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.L Sreerama and N E SladekDrug Metabolism and Disposition October 1995, 23 (10) 1080-1084;
Smith, B R
- You have accessRenal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J BugelskiDrug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
Sreerama, L
- You have accessHuman breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.L Sreerama and N E SladekDrug Metabolism and Disposition October 1995, 23 (10) 1080-1084;
Streiff, R R
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
T
Trimble, L A
- You have accessVerlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A YergeyDrug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
Twa, S P
- You have accessVerlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A YergeyDrug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
U
Urbanski, J J
- You have accessPreclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R RhodesDrug Metabolism and Disposition October 1995, 23 (10) 1028-1036;
- You have accessRenal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.T W Hepburn, C B Davis, J J Urbanski, B R Smith, W H Schaefer, M A Carbonaro and P J BugelskiDrug Metabolism and Disposition October 1995, 23 (10) 1044-1050;
V
Valles, B
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Veltman, J C
- You have accessMinimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.S G Sastry, R A Sanders, J C Veltman and J B WatkinsDrug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
Vickers, S
- You have accessUse of gender and oxygenation as synonyms for sex and oxidation.S VickersDrug Metabolism and Disposition October 1995, 23 (10) 1007;
Viger-Chougnet, A
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Vyas, K P
- You have accessDisposition of DMP 811 (L-708,404), a potent angiotensin II receptor antagonist, in the rat, monkey, and chimpanzee.K E Zhang and K P VyasDrug Metabolism and Disposition October 1995, 23 (10) 1104-1109;
W
Watkins, J B
- You have accessMinimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.S G Sastry, R A Sanders, J C Veltman and J B WatkinsDrug Metabolism and Disposition October 1995, 23 (10) 1094-1098;
Weimar, W R
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Wiegand, J
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Williams, H
- You have accessVerlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A YergeyDrug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
Wrighton, S A
- You have accessHuman liver lauric acid hydroxylase activities.P J Castle, J L Merdink, J R Okita, S A Wrighton and R T OkitaDrug Metabolism and Disposition October 1995, 23 (10) 1037-1043;
Wyss, R
- You have accessMetabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.B Valles, C D Schiller, P Coassolo, G De Sousa, R Wyss, D Jaeck, A Viger-Chougnet and R RahmaniDrug Metabolism and Disposition October 1995, 23 (10) 1051-1057;
Y
Yao, G W
- You have accessMetabolism and pharmacokinetics of N1,N11-diethylnorspermine.R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H DimovaDrug Metabolism and Disposition October 1995, 23 (10) 1117-1125;
Yergey, J A
- You have accessVerlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.D A Nicoll-Griffith, N Gupta, S P Twa, H Williams, L A Trimble and J A YergeyDrug Metabolism and Disposition October 1995, 23 (10) 1085-1093;
Yokel, R A
- You have accessInfluence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.R A Yokel, A M Fredenburg, K A Meurer and T L SkinnerDrug Metabolism and Disposition October 1995, 23 (10) 1178-1180;
Z
Zhang, K E
- You have accessDisposition of DMP 811 (L-708,404), a potent angiotensin II receptor antagonist, in the rat, monkey, and chimpanzee.K E Zhang and K P VyasDrug Metabolism and Disposition October 1995, 23 (10) 1104-1109;